ALSTOM (AOMD.DE) Stock Fundamental Analysis

FRA:AOMD • FR0010220475

28.34 EUR
+0.07 (+0.25%)
Last: Feb 27, 2026, 07:00 PM
Fundamental Rating

3

AOMD gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 109 industry peers in the Machinery industry. AOMD has a bad profitability rating. Also its financial health evaluation is rather negative. AOMD is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • In the past year AOMD was profitable.
  • In the past year AOMD had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: AOMD reported negative net income in multiple years.
  • The reported operating cash flow has been mixed in the past 5 years: AOMD reported negative operating cash flow in multiple years.
AOMD.DE Yearly Net Income VS EBIT VS OCF VS FCFAOMD.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B -1B 2B -2B 3B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 0.92%, AOMD is doing worse than 66.97% of the companies in the same industry.
  • The Return On Equity of AOMD (3.03%) is worse than 64.22% of its industry peers.
  • AOMD's Return On Invested Capital of 3.50% is on the low side compared to the rest of the industry. AOMD is outperformed by 64.22% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for AOMD is significantly below the industry average of 8.82%.
  • The last Return On Invested Capital (3.50%) for AOMD is above the 3 year average (2.36%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 0.92%
ROE 3.03%
ROIC 3.5%
ROA(3y)-0.31%
ROA(5y)-0.39%
ROE(3y)-1.2%
ROE(5y)-1.48%
ROIC(3y)2.36%
ROIC(5y)1.96%
AOMD.DE Yearly ROA, ROE, ROICAOMD.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60 80

1.3 Margins

  • Looking at the Profit Margin, with a value of 1.68%, AOMD is doing worse than 64.22% of the companies in the same industry.
  • AOMD's Profit Margin has declined in the last couple of years.
  • AOMD has a Operating Margin of 4.01%. This is in the lower half of the industry: AOMD underperforms 62.39% of its industry peers.
  • In the last couple of years the Operating Margin of AOMD has declined.
  • AOMD has a Gross Margin of 12.59%. This is amonst the worse of the industry: AOMD underperforms 93.58% of its industry peers.
  • In the last couple of years the Gross Margin of AOMD has declined.
Industry RankSector Rank
OM 4.01%
PM (TTM) 1.68%
GM 12.59%
OM growth 3Y69.79%
OM growth 5Y-11.95%
PM growth 3YN/A
PM growth 5Y-32.37%
GM growth 3Y3.78%
GM growth 5Y-6.9%
AOMD.DE Yearly Profit, Operating, Gross MarginsAOMD.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30 40

1

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), AOMD is destroying value.
  • The number of shares outstanding for AOMD has been increased compared to 1 year ago.
  • The number of shares outstanding for AOMD has been increased compared to 5 years ago.
  • AOMD has a better debt/assets ratio than last year.
AOMD.DE Yearly Shares OutstandingAOMD.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M
AOMD.DE Yearly Total Debt VS Total AssetsAOMD.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

2.2 Solvency

  • AOMD has an Altman-Z score of 0.96. This is a bad value and indicates that AOMD is not financially healthy and even has some risk of bankruptcy.
  • AOMD has a Altman-Z score of 0.96. This is in the lower half of the industry: AOMD underperforms 77.06% of its industry peers.
  • A Debt/Equity ratio of 0.31 indicates that AOMD is not too dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.31, AOMD is in line with its industry, outperforming 51.38% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Altman-Z 0.96
ROIC/WACC0.47
WACC7.42%
AOMD.DE Yearly LT Debt VS Equity VS FCFAOMD.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B -2B 4B 6B 8B 10B

2.3 Liquidity

  • AOMD has a Current Ratio of 0.97. This is a bad value and indicates that AOMD is not financially healthy enough and could expect problems in meeting its short term obligations.
  • AOMD has a Current ratio of 0.97. This is amonst the worse of the industry: AOMD underperforms 88.07% of its industry peers.
  • AOMD has a Quick Ratio of 0.97. This is a bad value and indicates that AOMD is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Quick ratio of AOMD (0.74) is worse than 74.31% of its industry peers.
Industry RankSector Rank
Current Ratio 0.97
Quick Ratio 0.74
AOMD.DE Yearly Current Assets VS Current LiabilitesAOMD.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

5

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 208.61% over the past year.
  • The earnings per share for AOMD have been decreasing by -29.24% on average. This is quite bad
  • The Revenue has been growing slightly by 4.58% in the past year.
  • AOMD shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 17.65% yearly.
EPS 1Y (TTM)208.61%
EPS 3YN/A
EPS 5Y-29.24%
EPS Q2Q%275.83%
Revenue 1Y (TTM)4.58%
Revenue growth 3Y6.12%
Revenue growth 5Y17.65%
Sales Q2Q%3.24%

3.2 Future

  • AOMD is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.96% yearly.
  • Based on estimates for the next years, AOMD will show a small growth in Revenue. The Revenue will grow by 3.94% on average per year.
EPS Next Y26.72%
EPS Next 2Y24.74%
EPS Next 3Y20.49%
EPS Next 5Y13.96%
Revenue Next Year3.39%
Revenue Next 2Y4.35%
Revenue Next 3Y4.51%
Revenue Next 5Y3.94%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
AOMD.DE Yearly Revenue VS EstimatesAOMD.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B 20B
AOMD.DE Yearly EPS VS EstimatesAOMD.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 0.5 1 1.5 2

3

4. Valuation

4.1 Price/Earnings Ratio

  • AOMD is valuated quite expensively with a Price/Earnings ratio of 41.68.
  • 62.39% of the companies in the same industry are cheaper than AOMD, based on the Price/Earnings ratio.
  • Compared to an average S&P500 Price/Earnings ratio of 27.10, AOMD is valued quite expensively.
  • A Price/Forward Earnings ratio of 12.85 indicates a correct valuation of AOMD.
  • Based on the Price/Forward Earnings ratio, AOMD is valued a bit cheaper than 72.48% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 28.06, AOMD is valued rather cheaply.
Industry RankSector Rank
PE 41.68
Fwd PE 12.85
AOMD.DE Price Earnings VS Forward Price EarningsAOMD.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AOMD is on the same level as its industry peers.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.39
AOMD.DE Per share dataAOMD.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

  • AOMD's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • AOMD's earnings are expected to grow with 20.49% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.56
PEG (5Y)N/A
EPS Next 2Y24.74%
EPS Next 3Y20.49%

4

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 2.03%, AOMD has a reasonable but not impressive dividend return.
  • AOMD's Dividend Yield is a higher than the industry average which is at 1.42.
  • AOMD's Dividend Yield is comparable with the S&P500 average which is at 1.80.
Industry RankSector Rank
Dividend Yield 2.03%

5.2 History

  • The dividend of AOMD decreases each year by -59.58%.
Dividend Growth(5Y)-59.58%
Div Incr Years0
Div Non Decr Years0
AOMD.DE Yearly Dividends per shareAOMD.DE Yearly Dividends per shareYearly Dividends per share 2017 2021 2022 2023 0.05 0.1 0.15 0.2

5.3 Sustainability

  • AOMD pays out 11.39% of its income as dividend. This is a sustainable payout ratio.
DP11.39%
EPS Next 2Y24.74%
EPS Next 3Y20.49%
AOMD.DE Yearly Income VS Free CF VS DividendAOMD.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B -1B 2B -2B 3B
AOMD.DE Dividend Payout.AOMD.DE Dividend Payout, showing the Payout Ratio.AOMD.DE Dividend Payout.PayoutRetained Earnings

ALSTOM

FRA:AOMD (2/27/2026, 7:00:00 PM)

28.34

+0.07 (+0.25%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)01-20
Earnings (Next)05-13
Inst Owners67.53%
Inst Owner ChangeN/A
Ins Owners0.04%
Ins Owner ChangeN/A
Market Cap13.09B
Revenue(TTM)18.77B
Net Income(TTM)316.00M
Analysts71.82
Price Target26.55 (-6.32%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.03%
Yearly Dividend0.06
Dividend Growth(5Y)-59.58%
DP11.39%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3.33%
PT rev (3m)9.92%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)1.93%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.35%
Revenue NY rev (3m)0.46%
Valuation
Industry RankSector Rank
PE 41.68
Fwd PE 12.85
P/S 0.7
P/FCF N/A
P/OCF 34.19
P/B 1.26
P/tB N/A
EV/EBITDA 10.39
EPS(TTM)0.68
EY2.4%
EPS(NY)2.21
Fwd EY7.79%
FCF(TTM)-0.24
FCFYN/A
OCF(TTM)0.83
OCFY2.93%
SpS40.63
BVpS22.55
TBVpS-1.17
PEG (NY)1.56
PEG (5Y)N/A
Graham Number18.57
Profitability
Industry RankSector Rank
ROA 0.92%
ROE 3.03%
ROCE 4.97%
ROIC 3.5%
ROICexc 3.6%
ROICexgc 14.09%
OM 4.01%
PM (TTM) 1.68%
GM 12.59%
FCFM N/A
ROA(3y)-0.31%
ROA(5y)-0.39%
ROE(3y)-1.2%
ROE(5y)-1.48%
ROIC(3y)2.36%
ROIC(5y)1.96%
ROICexc(3y)2.46%
ROICexc(5y)2.07%
ROICexgc(3y)19.81%
ROICexgc(5y)25.47%
ROCE(3y)3.35%
ROCE(5y)2.78%
ROICexgc growth 3Y15.87%
ROICexgc growth 5Y-22.05%
ROICexc growth 3Y72.68%
ROICexc growth 5Y-24.96%
OM growth 3Y69.79%
OM growth 5Y-11.95%
PM growth 3YN/A
PM growth 5Y-32.37%
GM growth 3Y3.78%
GM growth 5Y-6.9%
F-Score8
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Debt/EBITDA 2.04
Cap/Depr 58.83%
Cap/Sales 2.63%
Interest Coverage 250
Cash Conversion 24.07%
Profit Quality N/A
Current Ratio 0.97
Quick Ratio 0.74
Altman-Z 0.96
F-Score8
WACC7.42%
ROIC/WACC0.47
Cap/Depr(3y)53.94%
Cap/Depr(5y)55.69%
Cap/Sales(3y)2.66%
Cap/Sales(5y)2.75%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)208.61%
EPS 3YN/A
EPS 5Y-29.24%
EPS Q2Q%275.83%
EPS Next Y26.72%
EPS Next 2Y24.74%
EPS Next 3Y20.49%
EPS Next 5Y13.96%
Revenue 1Y (TTM)4.58%
Revenue growth 3Y6.12%
Revenue growth 5Y17.65%
Sales Q2Q%3.24%
Revenue Next Year3.39%
Revenue Next 2Y4.35%
Revenue Next 3Y4.51%
Revenue Next 5Y3.94%
EBIT growth 1Y32.57%
EBIT growth 3Y80.18%
EBIT growth 5Y3.59%
EBIT Next Year102.16%
EBIT Next 3Y36.81%
EBIT Next 5Y23.1%
FCF growth 1Y87.6%
FCF growth 3YN/A
FCF growth 5Y17.8%
OCF growth 1Y183.99%
OCF growth 3YN/A
OCF growth 5Y14.6%

ALSTOM / AOMD.DE FAQ

What is the fundamental rating for AOMD stock?

ChartMill assigns a fundamental rating of 3 / 10 to AOMD.DE.


What is the valuation status for AOMD stock?

ChartMill assigns a valuation rating of 3 / 10 to ALSTOM (AOMD.DE). This can be considered as Overvalued.


Can you provide the profitability details for ALSTOM?

ALSTOM (AOMD.DE) has a profitability rating of 2 / 10.


What is the valuation of ALSTOM based on its PE and PB ratios?

The Price/Earnings (PE) ratio for ALSTOM (AOMD.DE) is 41.68 and the Price/Book (PB) ratio is 1.26.


Can you provide the expected EPS growth for AOMD stock?

The Earnings per Share (EPS) of ALSTOM (AOMD.DE) is expected to grow by 26.72% in the next year.